20 commercial payer policies list Q2057. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
20 policies from 18 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of Q2057 |
|---|---|---|
| State and School Employees' Health Insurance Plan - Tecelra (afamitresgene autoleucel) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Tecelra (afamitresgene autoleucel) | Not recorded | Covered with conditionsInferred from policy title |
| Policy | Effective | Status of Q2057 |
|---|---|---|
| Tecelra (afamitresgene autoleucel) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Tecelra (afamitresgene autoleucel) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of Q2057 |
|---|---|---|
| Afamitresgene autoleucel (Tecelra) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of Q2057 |
|---|---|---|
| Afamitresgene autoleucel (e.g., Tecelra) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of Q2057 |
|---|---|---|
| Oncology Medications | Jul 1, 2026 | Covered |
| Policy | Effective | Status of Q2057 |
|---|---|---|
| Oncology Medications | Jul 1, 2026 | Covered |
| Policy | Effective | Status of Q2057 |
|---|---|---|
| Oncology Medications | Jul 1, 2026 | Covered |
| Policy | Effective | Status of Q2057 |
|---|---|---|
| Oncology Medications | Jul 1, 2026 | Covered |
| Policy | Effective | Status of Q2057 |
|---|---|---|
| TECELRA (AFAMITRESGENE AUTOLEUCEL) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of Q2057 |
|---|---|---|
| Afamitresgene Autoleucel (Tecelra) | Dec 3, 2024 | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of Q2057 |
|---|---|---|
| Tecelra (afamitresgene autoleucel) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of Q2057 |
|---|---|---|
| Afamitresgene Autoleucel (Tecelra); CP.PHAR.678 | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of Q2057 |
|---|---|---|
| Afamitresgene autoleucel (Tecelra) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of Q2057 |
|---|---|---|
| Tecelra (afamitresgene autoleucel) | May 1, 2026 | Covered |
| Policy | Effective | Status of Q2057 |
|---|---|---|
| Afamitresgene autoleucel (Tecelra) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of Q2057 |
|---|---|---|
| 00911 afamitresgene autoleucel (Tecelra) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of Q2057 |
|---|---|---|
| Tecelra | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of Q2057 |
|---|---|---|
| Tecelra (afamitresgene autoleucel) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |